Patient Registry Software Market

Patient Registry Software Market by Registry Type (Diabetes, Rare Disease, Cancer, Kidney), Software (Integrated, Standalone), Delivery (On Premise, Cloud), Functionality (PHM, HIE), Pricing Model, Database (Public), End User (Hospital) - Forecast to 2025

Report Code: HIT 3094 Aug, 2020, by marketsandmarkets.com

[255 Pages Report] The global patient registry software market is projected to reach USD 2.4 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 14.4% from 2020 to 2025. The growth of this market is mainly attributed to the shift toward computerized registries from paper-based registries, due to their advantages, is a key driver of market growth. The emergence of the COVID-19 pandemic and the increase in the number of COVID-19 patients globally is also expected to support the demand for patient registry software. Other considerations include the rising number of accountable care organizations, high adoption of the subscription model, and the emergence of cloud-based patient registry solutions. However, shortage of trained and skilled resources and privacy and data security related concerns hampered market growth to an extent.

In this report, the patient registry software market is segmented on the basis of type of registry, software, pricing model, deployment model, type of database, functionality, end user, and region.

Patient Registry Software Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the Patient Registry Software Market

The emergence of the COVID-19 pandemic has increased the demand for patient registries, as they help researchers understand the disease prognosis and help physicians determine the best method to treat COVID-19 patients. Also, patient registries help in the collection of real-world evidence of clinical encounters and provide opportunities to potentially study the clinical effectiveness of treatments for different patient populations.

As per several studies, patients with predetermined health problems, such as cardiovascular diseases and cancer, are more prone to suffer from severe COVID-19 symptoms. Data from patient registries provides valuable insights into patient characteristics, treatment patterns, and clinical outcomes in patients who are hospitalized with predetermined diseases. Many government organizations have launched patient registries specifically to understand the impact of COVID-19 on patients previously suffering from different diseases. Thus, there is an increase in the number of patient registries for cardiovascular diseases and cancer that are specifically launched to understand the effects of COVID-19 on these patients.

Patient Registry Software Market Dynamics

Drivers: Rising adoption of EHRs and other eHealth solutions

Globally, the adoption of electronic health records (EHRs) and other HCIT solutions is increasing, which is considered a positive indicator for the patient registry software market. This is because patient registry software functionality is included or is available as an add-on for many EHR products. Authorities in several countries are focusing on the greater adoption of EHR solutions in their healthcare systems to help improve the delivery of healthcare services. For instance, among office-based physicians in the US, EHR implementation increased from 72% in 2012 to 85.9% in 2018 (Source: National Center for Health Statistics, 2012). The increasing use of EHR in developed and developing countries is resulting in improved patient care, increased patient participation, and easy collection and storage of patient health information in a digital format. The widespread transition from paper-based records to electronic records is expected to boost the demand for integrated patient registry software.

Restrains: Privacy- and data security-related concerns

Concerns related to data privacy and security are affecting the adoption of patient registry solutions among healthcare organizations, as the breach of a data registry can potentially expose confidential information of a large number of patients. In recent years, there has been significant growth in the number of healthcare data breaches. In healthcare, approximately one-third of data breaches result in medical identity theft, mainly due to a lack of internal control over patient information, outdated policies and procedures or non-adherence to existing ones, and inadequate personnel training. In the US, the Identity Theft Resource Center recorded 1,473 breaches in its 2019 breach list, an increase of 17% over the total number of breaches tracked in 2018. The healthcare sector alone accounted for 35.5% of the total tracked breaches. Such risk factors may hamper the patient registry software market to a certain extent.

Opportunities: Emergence of cloud-based patient registry solutions

Cloud-based patient registry solutions have emerged as effective tools that offer end users enhanced data accessibility and real-time analysis. Moreover, these solutions are user friendly, scalable, and adaptable for any specialty or organization.

The use of cloud-based patient registry solutions helps deliver insights from a multi-terabyte database anywhere, anytime, and on any platform, with ease. In addition, these solutions do not require any upfront capital investment for hardware and provide faster data transfer between organizations. Considering these advantages, the preference for cloud-based patient registry solutions is expected to increase among end users during the forecast period.

Challenges:Reluctance to adopt advanced solutions

The continued use of existing paper-based and unorganized computer-based registry tools is restricting the implementation of advanced HCIT solutions, such as patient registry solutions, especially in developing countries. Many hospitals and physicians, particularly in small and rural areas, continue to rely on basic existing methods such as spreadsheets or case paper-based patient registry methods. These tools are only used at the department level, with retrospective data. In this approach, reports are considered as being good for a specific period until they become too inefficient to continue. Furthermore, many hospitals and other end users are opposed to adopting advanced EHR systems and patient registry software due to the costs associated with the software purchase and implementation, coupled with the lack of operating skills for these advanced tools.

The disease registries segment is estimated to grow at the highest CAGR in the patient registry software, by type of registry market, in 2019

Based on the type of registry, the patient registry software market is segmented into product registries, health service registries, and disease registries. The disease registries segment accounted for the largest share and estimated to grow at the highest CAGR of the patient registry software market in 2019. The large share of this segment can be attributed to the increase in the aging population, rising prevalence of chronic and rare & new diseases, growing awareness on the role of registries in health management, and the adoption of EHRs across the globe.

The standalone software segment will dominate the patient registry software, by type of software market during the forecast period

Based on the type of software, the patient registry software market is segmented into standalone and integrated software. The standalone software segment accounted for the largest share of the global patient registry software market. The large share of this segment can be attributed to the significant use of standalone software by government organizations & TPAs for population health management due to its adaptability and interoperability.

The Population Health Management (PHM) segment will dominate the patient registry software, by functionality market during the forecast period

Based on functionality, the patient registry software market is segmented into population health management (PHM), patient care management, health information exchange (HIE), point of care, product outcome evaluation, and medical research & clinical studies. The patient registry software market for accounted for the largest share of the global patient registry software market. This can be attributed to government initiatives to boost the adoption of patient registry software by hospitals & medical practices, implementation of the ACA in the US, which encourages PHM, and the availability of government funding. Besides, the emergence of the COVID-19 outbreak has led to the launch of COVID-19 patient registries worldwide. However, data integration between different hospitals and medical organizations and the possibility of errors due to human intervention can negatively affect this market.

Government Organizations & TPAs are the largest end users of patient registry software

Based on the end user, the patient registry software market is segmented into private payers; hospitals & medical practices; research centers; pharmaceutical, biotechnology, & medical device companies; and government organizations & TPAs. In 2019, the government organizations & TPAs segment accounted for the largest share of the global patient registry software market. The large share of this segment can be attributed to the emergence of the COVID-19 pandemic and the need for analyzing patient data for better population health management.

Asia Pacific market to witness the highest growth during the forecast period

The patient registry software market is divided into five regions North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. These regions are further analyzed at the country levels. North America held the largest share of the patient registry software market in 2019, followed by Europe and the Asia Pacific. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by the increasing incidence of chronic diseases, rising awareness about the benefits of EHRs, improvements in healthcare systems, the development of medical tourism in Asian countries, high demand for EHRs in Asian countries. increasing government initiatives for the modernization of healthcare infrastructure, and the growing number of ongoing research activities.

Patient Registry Software Market   by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

The products and services market is dominated by a few globally established players such as include Phytel, IQVIA Holdings, FIGmd, OpenText Corporation, Dacima Software, Global Vision Technologies, ifa systems, Syneos Health, and HealthDiary

Report Metric

Details

Market size available for years

2018-2025

Base year considered

2019

Forecast period

2020–2025

Forecast units

Value (USD)

Segments covered

By Type of Registry, Software, Pricing Model, Deployment Model, Type of Database, Functionality, and End User.

Geographies covered

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies covered

The major market players include Phytel, Inc. (US), IQVIA Holdings, Inc. (US), OpenText Corporation (Canada), ImageTrend, Inc. (US), FIGmd, Inc. (US), McKesson Corporation (US), CECity.com Inc. (a Premier, Inc. Company) (US), Dacima Software Inc. (Canada), Global Vision Technologies, Inc. (US), ifa systems AG, (Germany), Syneos Health Inc. (US), M2S (a Medstreaming Company) (US), Optum, Inc. (a part of UnitedHealth Group Incorporated) (US), Evado Pty. Ltd. (Australia), Velos, LLC. (US), Cedaron (US), ArborMetrix Inc.(US), LUMEDX (US), HealthDiary Inc. (Canada) and phamax (Switzerland).

The study categorizes the patient registry software market based on Type of Registry, Software, Pricing Model, Deployment Model, Type of Database, Functionality, and End User at the regional and global level.

By Type of Registry

  • Disease Registries
    • Diabetes Registries
    • Cardiovascular Registries
    • Cancer Registries
    • Rare Disease Registries
    • Asthma Registries
    • Chronic Kidney Disease Registries
    • Orthopedic Registries
    • Other Registries
  • Health Service Registries
  • Product Registries
    • Medical Device Registries
    • Drug Registries

By Type of Softwar

  • Standalone Software
  • Integrated Software

By Pricing Model

  • Subscription Model
  • Ownership Model

By Deployment Model

  • On-Premise Models
  • Cloud-Based Models

By Type of Database

  • Commercial Databases
  • Public Databases

By Functionality

  • Population Health Management (PHM)
  • Patient Care Management
  • Health Information Exchange
  • Point-Of-Care
  • Product Outcome Evaluation
  • Medical Research & Clinical Studies

By End Users

  • Government Organizations & Third-Party Administrators (TPAs)
  • Hospitals and Medical Practices
  • Private Payers
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Research Centers

Recent Developments

  • In June 2020, ArborMetrix Inc. (US) entered into a partnership with The Society of Interventional Radiology (SIR) (US) . This partnership aims to provide the IR Quality Registry to improve patient care by integrating analytics.
  • In April 2020, IQVIA Holdings Inc. (US), announced the launch COVID-19 registry platform and technology-powered trial matching solution
  • In March 2020, OpenText Corporation (Canada) acquired XMedius (US) To strengthen OpenText’s leadership in the areas of secure information exchange, unified communications, and digital fax.
  • In March 2020, ImageTrend Inc. (US) entered into a partnership with American Heart Association (US) , in this partnership ImageTrend’s Clinical and Research team will analyze pre-hospital data related to heart attacks and strokes in patients during the COVID-19 pandemic.
  • InJanuary 2020, M2S . (US) announced the launch Vascular Medicine Consult Registry.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS & EXCLUSIONS
           1.2.2 MARKETS COVERED
           1.2.3 YEARS CONSIDERED FOR THE STUDY
    1.3 CURRENCY
    1.4 LIMITATIONS
    1.5 STAKEHOLDERS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 32)
    2.1 RESEARCH APPROACH
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
    2.2 MARKET SIZE ESTIMATION
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    2.4 MARKET SHARE ANALYSIS
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 42)

4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 PATIENT REGISTRY SOFTWARE MARKET OVERVIEW
    4.2 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET,  BY TYPE OF REGISTRY AND COUNTRY (2019)
    4.3 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    4.4 REGIONAL MIX: PATIENT REGISTRY SOFTWARE MARKET (2020−2025)
    4.5 PATIENT REGISTRY SOFTWARE MARKET: DEVELOPING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW (Page No. - 55)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 MARKET DRIVERS
                    5.2.1.1 Implementation of government initiatives to build patient registries
                    5.2.1.2 Rising pressure to improve the quality of care and reduce healthcare costs
                    5.2.1.3 Rising adoption of EHRs and other eHealth solutions
                    5.2.1.4 Growing patient volume due to the global outbreak of COVID-19
                    5.2.1.5 Growing use of patient registry data for post-marketing surveillance
           5.2.2 MARKET RESTRAINTS
                    5.2.2.1 Privacy- and data security-related concerns
                    5.2.2.2 Shortage of trained and skilled resources
           5.2.3 MARKET OPPORTUNITIES
                    5.2.3.1 Rising number of accountable care organizations
                    5.2.3.2 Emergence of cloud-based patient registry solutions
                    5.2.3.3 High adoption rate of the subscription model
           5.2.4 MARKET CHALLENGES
                    5.2.4.1 Lack of interoperability and integration
                    5.2.4.2 Reluctance to adopt advanced solutions
                    5.2.4.3 Lack of awareness

6 INDUSTRY INSIGHTS (Page No. - 61)
    6.1 INTRODUCTION
    6.2 IMPACT OF COVID-19 ON THE PATIENT REGISTRY SOFTWARE MARKET
           6.2.1 SHIFTING FOCUS TOWARD PATIENT-POWERED RESEARCH NETWORKS
    6.3 HCIT EXPENDITURE ANALYSIS
           6.3.1 NORTH AMERICA
           6.3.2 EUROPE
           6.3.3 ASIA PACIFIC
    6.4 HCIT ADOPTION TRENDS IN THE US

7 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY (Page No. - 66)
    7.1 INTRODUCTION
    7.2 DISEASE REGISTRIES
           7.2.1 DIABETES REGISTRIES
                    7.2.1.1 Growing obese and geriatric populations to drive market growth
           7.2.2 CARDIOVASCULAR REGISTRIES
                    7.2.2.1 Rising prevalence of heart diseases and strokes worldwide to drive market growth
           7.2.3 CANCER REGISTRIES
                    7.2.3.1 Increasing need to manage the growing number of cancer patients across the globe to propel market growth
           7.2.4 RARE DISEASE REGISTRIES
                    7.2.4.1 Increasing funding for research on rare diseases and their treatments to boost market growth
           7.2.5 ASTHMA REGISTRIES
                    7.2.5.1 Increasing prevalence of asthma is one of the major drivers for market growth
           7.2.6 CHRONIC KIDNEY DISEASE REGISTRIES
                    7.2.6.1 Rising prevalence of chronic kidney diseases to drive market growth
           7.2.7 ORTHOPEDIC REGISTRIES
                    7.2.7.1 Growing number of patients suffering from orthopedic diseases to drive market growth
           7.2.8 OTHER DISEASE REGISTRIES
    7.3 HEALTH SERVICE REGISTRIES
           7.3.1 THESE REGISTRIES CAPTURE SERVICE-GENERATED DATA DERIVED FROM HEALTH FACILITIES
    7.4 PRODUCT REGISTRIES
           7.4.1 MEDICAL DEVICE REGISTRIES
                    7.4.1.1 Strong government support and initiatives to drive the demand for medical device registries
           7.4.2 DRUG REGISTRIES
                    7.4.2.1 Increasing post-marketing surveillance of drugs to drive market growth

8 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE (Page No. - 89)
    8.1 INTRODUCTION
    8.2 STANDALONE SOFTWARE
           8.2.1 STANDALONE SOFTWARE WILL CONTINUE TO DOMINATE THE MARKET IN THE FORECAST PERIOD
    8.3 INTEGRATED SOFTWARE
           8.3.1 INTEGRATED SOFTWARE SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD

9 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL (Page No. - 95)
    9.1 INTRODUCTION
    9.2 SUBSCRIPTION MODEL
           9.2.1 LOW COST OF SUBSCRIPTION MODELS TO SUPPORT THE GROWTH OF THIS SEGMENT
    9.3 OWNERSHIP MODEL
           9.3.1 RISING ADOPTION OF THE INTEGRATED SOFTWARE MODEL WILL SUPPORT THE GROWTH OF THIS SEGMENT

10 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL (Page No. - 99)
     10.1 INTRODUCTION
     10.2 ON-PREMISE MODEL
             10.2.1 ON-PREMISE SOLUTIONS REDUCE THE RISK OF DATA BREACHES AND OTHER SECURITY ISSUES
     10.3 CLOUD-BASED MODEL
             10.3.1 CLOUD-BASED SOLUTIONS HELP HEALTHCARE ORGANIZATIONS SHARE AND INTEGRATE INFORMATION FROM DISPARATE  LOCATIONS IN REAL-TIME

11 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE (Page No. - 105)
     11.1 INTRODUCTION
     11.2 COMMERCIAL DATABASES
             11.2.1 COMMERCIAL REGISTRIES ARE GENERALLY PRIVATELY FUNDED OR INDUSTRY-SPONSORED
     11.3 PUBLIC DATABASES
             11.3.1 PUBLIC REGISTRIES ARE FUNDED BY FEDERAL, STATE, OR LOCAL GOVERNMENT AGENCIES

12 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY (Page No. - 111)
     12.1 INTRODUCTION
     12.2 POPULATION HEALTH MANAGEMENT
             12.2.1 INCREASING DEMAND FOR QUALITY CARE IS DRIVING THE ADOPTION OF PHM SOLUTIONS
     12.3 PATIENT CARE MANAGEMENT
             12.3.1 GOVERNMENT INITIATIVES AND REGULATIONS PROMOTING PATIENT-CENTRIC CARE TO DRIVE MARKET GROWTH
     12.4 MEDICAL RESEARCH & CLINICAL STUDIES
             12.4.1 CONTINUOUS RESEARCH FOR THE MAKING THE VACCINE FOR COVID-19 AVAILABLE, IS SUPPORTING THE GROWTH OF THIS SEGMENT.
     12.5 HEALTH INFORMATION EXCHANGE
             12.5.1 INCREASING NEED FOR SHARING OF VITAL PATIENT INFORMATION WITH CARE PROVIDERS SUPPORTS ADOPTION OF SOLUTIONS
     12.6 POINT OF CARE
             12.6.1 URGENT NEED FOR STREAMLINED PATIENT CARE PROCESS TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
     12.7 PRODUCT OUTCOME EVALUATION
             12.7.1 INCREASING POST-MARKETING SURVEILLANCE IN BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES IS LIKELY TO PROPEL MARKET GROWTH

13 PATIENT REGISTRY SOFTWARE MARKET, BY END USER (Page No. - 120)
     13.1 INTRODUCTION
     13.2 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS
             13.2.1 GOVERNMENT ORGANIZATIONS & THIRD-PARTY ADMINISTRATORS HOLD LARGEST SHARE IN THE END-USER MARKET
     13.3 HOSPITALS & MEDICAL PRACTICES
             13.3.1 DEMAND FOR REGISTRY SOFTWARE SUPPORTED BY A GROWING FOCUS ON PATIENT SAFETY AND IMPROVING PATIENT OUTCOMES
     13.4 PRIVATE PAYERS
             13.4.1 NEED TO CURB RISING HEALTHCARE COSTS TO DRIVE MARKET GROWTH
     13.5 PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES
             13.5.1 EVOLVING REGULATORY GUIDELINES ON PATIENT SAFETY BY REGULATORY BODIES TO PROPEL THE GROWTH OF THIS MARKET SEGMENT
     13.6 RESEARCH CENTERS
             13.6.1 INCREASE IN CLINICAL TRIALS & RESEARCH ON DISEASE TREATMENT SUPPORTS THE GROWTH OF THIS MARKET SEGMENT

14 PATIENT REGISTRY SOFTWARE MARKET, BY REGION (Page No. - 128)
     14.1 INTRODUCTION
     14.2 NORTH AMERICA
             14.2.1 US
                       14.2.1.1 The US is the largest market for patient registry software
             14.2.2 CANADA
                       14.2.2.1 Launch of new government initiative is expected to drive the adoption of Patient Registry Software across the country
     14.3 EUROPE
             14.3.1 UK
                       14.3.1.1 Government initiatives to support market growth
             14.3.2 GERMANY
                       14.3.2.1 High healthcare spending to support the adoption of patient registry software solutions in Germany
             14.3.3 FRANCE
                       14.3.3.1 Large number of COVID-19 cases to support market growth
             14.3.4 ITALY
                       14.3.4.1 Rising prevalence of chronic diseases to increase the demand for patient registry software
             14.3.5 SPAIN
                       14.3.5.1 Government initiatives to improve the adoption of patient registry software and eHealth solutions are major market drivers
             14.3.6 REST OF EUROPE
     14.4 ASIA PACIFIC
             14.4.1 JAPAN
                       14.4.1.1 Japan has one of the highest adoption rates of EMR and patient registry software solutions in the Asia Pacific
             14.4.2 CHINA
                       14.4.2.1 Absence of a patient-centered model may challenge the adoption of patient registry software and related markets in the country
             14.4.3 INDIA
                       14.4.3.1 India is currently one of the lucrative emerging regions in  the field of eHealth
             14.4.4 REST OF ASIA PACIFIC
     14.5 LATIN AMERICA
             14.5.1 LATIN AMERICA HAS A LOWER ADOPTION RATE OF EHR SOLUTIONS
     14.6 MIDDLE EAST & AFRICA
             14.6.1 IMPLEMENTATION OF PATIENT REGISTRY SOFTWARE ACROSS PRIVATE SECTORS HAS BEEN EXTREMELY SLOW PACED

15 COMPETITIVE LANDSCAPE (Page No. - 211)
     15.1 OVERVIEW
     15.2 COMPETITIVE LEADERSHIP MAPPING
             15.2.1 STARS
             15.2.2 EMERGING LEADERS
             15.2.3 PERVASIVE COMPANIES
             15.2.4 EMERGING COMPANIES
     15.3 PRODUCT MATRIX, BY COMPANY
     15.4 MARKET SHARE ANALYSIS
     15.5 COMPETITIVE SITUATIONS & TRENDS
             15.5.1 PRODUCT LAUNCHES
             15.5.2 PARTNERSHIPS, AGREEMENTS, & COLLABORATIONS
             15.5.3 ACQUISITIONS

16 COMPANY PROFILES (Page No. - 218)
     16.1 PHYTEL
             16.1.1 BUSINESS OVERVIEW
             16.1.2 PRODUCTS OFFERED
             16.1.3 RECENT DEVELOPMENTS
             16.1.4 MNM VIEW
             16.1.5 STRATEGIC OVERVIEW
     16.2 IQVIA HOLDINGS
             16.2.1 BUSINESS OVERVIEW
             16.2.2 PRODUCTS OFFERED
             16.2.3 RECENT DEVELOPMENTS
             16.2.4 MNM VIEW
             16.2.5 STRATEGIC OVERVIEW
     16.3 OPENTEXT CORPORATION
             16.3.1 BUSINESS OVERVIEW
             16.3.2 PRODUCTS OFFERED
             16.3.3 RECENT DEVELOPMENTS
             16.3.4 MNM VIEW
             16.3.5 STRATEGIC OVERVIEW
     16.4 SYNEOS HEALTH
             16.4.1 BUSINESS OVERVIEW
             16.4.2 PRODUCTS OFFERED
             16.4.3 RECENT DEVELOPMENTS
             16.4.4 MNM VIEW
             16.4.5 STRATEGIC OVERVIEW
     16.5 FIGMD
             16.5.1 BUSINESS OVERVIEW
             16.5.2 PRODUCTS OFFERED
             16.5.3 RECENT DEVELOPMENTS
             16.5.4 STRATEGIC OVERVIEW
     16.6 IMAGETREND
             16.6.1 BUSINESS OVERVIEW
             16.6.2 PRODUCTS OFFERED
             16.6.3 RECENT DEVELOPMENTS
     16.7 CECITY.COM
             16.7.1 BUSINESS OVERVIEW
             16.7.2 PRODUCTS OFFERED
             16.7.3 RECENT DEVELOPMENTS
     16.8 DACIMA SOFTWARE
             16.8.1 BUSINESS OVERVIEW
             16.8.2 PRODUCTS OFFERED
             16.8.3 RECENT DEVELOPMENTS
     16.9 GLOBAL VISION TECHNOLOGIES
             16.9.1 BUSINESS OVERVIEW
             16.9.2 PRODUCTS OFFERED
     16.10 IFA SYSTEMS AG
               16.10.1 BUSINESS OVERVIEW
               16.10.2 PRODUCTS OFFERED
     16.11 M2S
               16.11.1 BUSINESS OVERVIEW
               16.11.2 PRODUCTS OFFERED
               16.11.3 RECENT DEVELOPMENTS
     16.12 MCKESSON CORPORATION
               16.12.1 BUSINESS OVERVIEW
               16.12.2 PRODUCTS & SERVICES OFFERED
               16.12.3 RECENT DEVELOPMENTS
     16.13 OPTUM
               16.13.1 BUSINESS OVERVIEW
               16.13.2 PRODUCTS OFFERED
               16.13.3 RECENT DEVELOPMENTS
     16.14 EVADO CLINICAL
               16.14.1 BUSINESS OVERVIEW
               16.14.2 PRODUCTS OFFERED
               16.14.3 RECENT DEVELOPMENTS
     16.15 VELOS
               16.15.1 BUSINESS OVERVIEW
               16.15.2 PRODUCTS OFFERED
               16.15.3 RECENT DEVELOPMENTS
     16.16 ARBORMETRIX
               16.16.1 BUSINESS OVERVIEW
               16.16.2 PRODUCTS OFFERED
               16.16.3 RECENT DEVELOPMENTS
     16.17 LUMEDX
     16.18 HEALTHDIARY
     16.19 CEDARON
     16.20 PHAMAX AG

17 APPENDIX (Page No. - 246)
     17.1 INSIGHTS OF INDUSTRY EXPERTS
     17.2 DISCUSSION GUIDE
     17.3 KNOWLEDGE STORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL
     17.4 AVAILABLE CUSTOMIZATIONS
     17.5 RELATED REPORTS
     17.6 AUTHOR DETAILS


LIST OF TABLES (230 Tables)

TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
TABLE 2 COVID-19 PATIENT REGISTRIES
TABLE 3 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY
TABLE 4 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 5 DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 6 DISEASE REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 DIABETES REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 8 DIABETES REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 9 CARDIOVASCULAR REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 10 CARDIOVASCULAR REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 CANCER REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 12 CANCER REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 RARE DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 14 RARE DISEASE REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 ASTHMA REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 16 ASTHMA REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 CHRONIC KIDNEY DISEASE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 18 CHRONIC KIDNEY DISEASE REGISTRIES MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 19 ORTHOPEDIC REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 20 ORTHOPEDIC REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 OTHER DISEASE REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 HEALTH SERVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 23 HEALTH SERVICE REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 25 PRODUCT REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 MEDICAL DEVICE REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 27 MEDICAL DEVICE REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 DRUGS REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS/ORGANIZATIONS
TABLE 29 DRUG REGISTRIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 31 STANDALONE SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 32 STANDALONE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 33 INTEGRATED SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 34 INTEGRATED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY  2018–2025 (USD MILLION)
TABLE 35 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 36 SUBSCRIPTION-BASED PATIENT REGISTRY SOFTWARE MARKET,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 OWNERSHIP-BASED PATIENT REGISTRY SOFTWARE MARKET,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 39 ON-PREMISE PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 40 ON-PREMISE PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 41 CLOUD-BASED PATIENT REGISTRY SOFTWARE OFFERED BY KEY MARKET PLAYERS
TABLE 42 CLOUD-BASED PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 43 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 44 PATIENT REGISTRY SOFTWARE FOR COMMERCIAL DATABASES OFFERED BY KEY MARKET PLAYERS
TABLE 45 PATIENT REGISTRY SOFTWARE MARKET FOR COMMERCIAL DATABASES,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 PATIENT REGISTRY SOFTWARE FOR PUBLIC DATABASES OFFERED  BY KEY MARKET PLAYERS
TABLE 47 PATIENT REGISTRY SOFTWARE MARKET FOR PUBLIC DATABASES, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 48 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 49 PATIENT REGISTRY SOFTWARE MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 50 PATIENT REGISTRY SOFTWARE MARKET FOR PATIENT CARE MANAGEMENT,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 PATIENT REGISTRY SOFTWARE MARKET FOR MEDICAL RESEARCH & CLINICAL STUDIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 PATIENT REGISTRY SOFTWARE MARKET FOR HEALTH INFORMATION EXCHANGE,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 53 PATIENT REGISTRY SOFTWARE MARKET FOR POINT OF CARE, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 54 PATIENT REGISTRY SOFTWARE MARKET FOR PRODUCT OUTCOME EVALUATION,  BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 56 PATIENT REGISTRY SOFTWARE MARKET FOR GOVERNMENT ORGANIZATIONS & TPAS,  BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 57 PATIENT REGISTRY SOFTWARE MARKET FOR HOSPITALS & MEDICAL PRACTICES,  BY REGION, 2018-2025 (USD MILLION)
TABLE 58 PATIENT REGISTRY SOFTWARE MARKET FOR PRIVATE PAYERS, BY REGION,  2018-2025 (USD MILLION)
TABLE 59 PATIENT REGISTRY SOFTWARE MARKET FOR PHARMACEUTICAL, BIOTECHNOLOGY, AND MEDICAL DEVICE COMPANIES, BY REGION, 2018

-2025 (USD MILLION)
TABLE 60 PATIENT REGISTRY SOFTWARE MARKET FOR RESEARCH CENTERS, BY REGION,  2018-2025 (USD MILLION)
TABLE 61 PATIENT REGISTRY SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 62 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 63 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 64 NORTH AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 65 NORTH AMERICA: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 67 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 68 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION)
TABLE 69 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 70 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 71 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 72 US: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
TABLE 73 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 74 US: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 US: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 77 US: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 78 US: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 79 US: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 80 US: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 81 US: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 82 CANADA: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
TABLE 83 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 84 CANADA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 85 CANADA: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 87 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 88 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 89 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 90 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 91 CANADA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 92 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY/REGION,  2018–2025 (USD MILLION)
TABLE 93 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 94 EUROPE: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 EUROPE: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 97 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 98 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 99 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 100 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 101 EUROPE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 102 UK: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
TABLE 103 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 104 UK: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 UK: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 106 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 107 UK: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 108 UK: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 109 UK: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 110 UK: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 111 UK: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 112 GERMANY: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
TABLE 113 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 114 GERMANY: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 GERMANY: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 117 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 118 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 119 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 120 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 121 GERMANY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 122 FRANCE: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
TABLE 123 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 124 FRANCE: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 125 FRANCE: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 126 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 127 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 128 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 129 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 130 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 131 FRANCE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 132 ITALY: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
TABLE 133 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 134 ITALY: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 ITALY: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 137 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 138 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 139 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 140 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 141 ITALY: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 142 SPAIN: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
TABLE 143 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 144 SPAIN: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145 SPAIN: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 146 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 147 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 148 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 149 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 150 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 151 SPAIN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 152 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 153 ROE: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 154 ROE: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 155 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 156 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 157 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 158 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 159 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 160 ROE: PATIENT REGISTRY SOFTWARE MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 161 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY COUNTRY,  2018–2025 (USD MILLION)
TABLE 162 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 163 ASIA PACIFIC: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 ASIA PACIFIC: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 165 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 166 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 167 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 168 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 169 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 170 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 171 JAPAN: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
TABLE 172 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 173 JAPAN: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 174 JAPAN: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 175 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 176 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 177 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 178 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 179 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 180 JAPAN: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 181 CHINA: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
TABLE 182 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 183 CHINA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 184 CHINA: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 185 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 186 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 187 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 188 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 189 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 190 CHINA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 191 INDIA: MACROECONOMIC INDICATORS FOR THE PATIENT REGISTRY SOFTWARE MARKET
TABLE 192 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 193 INDIA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 194 INDIA: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 195 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 196 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 197 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 198 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 199 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 200 INDIA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 201 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 202 ROAPAC: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 203 ROAPAC: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 205 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 206 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 207 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 208 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 209 ROAPAC: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 210 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2018–2025 (USD MILLION)
TABLE 211 LATIN AMERICA: PRODUCT REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 212 LATIN AMERICA: DISEASE REGISTRIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 213 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2018–2025 (USD MILLION)
TABLE 214 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2018–2025 (USD MILLION)
TABLE 215 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2018–2025 (USD MILLION)
TABLE 216 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2018–2025 (USD MILLION)
TABLE 217 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2018–2025 (USD MILLION)
TABLE 218 LATIN AMERICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY, 2018–2025 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: PRODUCT REGISTRIES MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: DISEASE REGISTRIES MARKET, BY TYPE,  2018–2025 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE, 2018–2025 (USD MILLION)
TABLE 223 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL, 2018–2025 (USD MILLION)
TABLE 224 MIDDLE EAST & AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL, 2018–2025 (USD MILLION)
TABLE 225 MIDDLE EAST AND AFRICA: PATIENT REGISTRY SOFTWARE MARKET,  BY TYPE OF DATABASE, 2018–2025 (USD MILLION)
TABLE 226 MIDDLE EAST AND AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY, 2018–2025 (USD MILLION)
TABLE 227 MIDDLE EAST AND AFRICA: PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2018–2025 (USD MILLION)
TABLE 228 KEY PRODUCT LAUNCHES
TABLE 229 KEY PARTNERSHIPS, AGREEMENTS, & COLLABORATIONS
TABLE 230 KEY ACQUISITIONS
 
 
LIST OF FIGURES (38 Figures)
 
FIGURE 1 PATIENT REGISTRY SOFTWARE MARKET
FIGURE 2 RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 8 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF REGISTRY,  2020 VS. 2025 (USD MILLION)
FIGURE 9 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF SOFTWARE,  2020 VS. 2025 (USD MILLION)
FIGURE 10 PATIENT REGISTRY SOFTWARE MARKET, BY PRICING MODEL,  2020 VS. 2025 (USD MILLION)
FIGURE 11 PATIENT REGISTRY SOFTWARE MARKET, BY DEPLOYMENT MODEL,  2020 VS. 2025 (USD MILLION)
FIGURE 12 PATIENT REGISTRY SOFTWARE MARKET, BY TYPE OF DATABASE,  2020 VS. 2025 (USD MILLION)
FIGURE 13 PATIENT REGISTRY SOFTWARE MARKET, BY FUNCTIONALITY,  2020 VS. 2025 (USD MILLION)
FIGURE 14 PATIENT REGISTRY SOFTWARE MARKET, BY END USER,  2020 VS. 2025 (USD MILLION)
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE PATIENT REGISTRY SOFTWARE MARKET
FIGURE 16 RISING ADOPTION OF ELECTRONIC HEALTH RECORDS AND OTHER E-HEALTH SOLUTIONS ARE DRIVING MARKET GROWTH
FIGURE 17 DISEASE REGISTRIES ACCOUNTED FOR THE LARGEST SHARE OF THE APAC PATIENT REGISTRY SOFTWARE MARKET IN 2019
FIGURE 18 CHINA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 19 NORTH AMERICA WILL CONTINUE TO DOMINATE THE PATIENT REGISTRY SOFTWARE MARKET IN 2025
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD
FIGURE 21 PATIENT REGISTRY SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 US: OFFICE-BASED PHYSICIAN EHR ADOPTION (2004–2017)
FIGURE 23 US: HOSPITAL EHR ADOPTION (2007–2018)
FIGURE 24 PATIENT REGISTRY SOFTWARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 25 NORTH AMERICA: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: PATIENT REGISTRY SOFTWARE MARKET SNAPSHOT
FIGURE 27 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS, AGREEMENTS, & COLLABORATIONS WERE THE MOST WIDELY ADOPTED STRATEGIES
FIGURE 28 PATIENT REGISTRY SOFTWARE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 29 R&D EXPENDITURE BY KEY PLAYERS IN THE PATIENT REGISTRY SOFTWARE MARKET, 2018 VS. 2019 (USD MILLION)
FIGURE 30 PATIENT REGISTRY SOFTWARE MARKET RANKING ANALYSIS, BY PLAYER, 2019
FIGURE 31 IBM CORPORATION: COMPANY SNAPSHOT
FIGURE 32 IQVIA HOLDINGS: COMPANY SNAPSHOT (2019)
FIGURE 33 OPENTEXT CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 34 SYNEOS HEALTH: COMPANY SNAPSHOT (2019)
FIGURE 35 PREMIER: COMPANY SNAPSHOT
FIGURE 36 IFA SYSTEMS AG: COMPANY SNAPSHOT (2018)
FIGURE 37 MCKESSON CORPORATION: COMPANY SNAPSHOT (2020)
FIGURE 38 OPTUM: COMPANY SNAPSHOT (2019)

This study involved four major activities for estimating the current size of the patient registry software market. Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets. The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Revenue Share Analysis, Parent Market and top-down approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the sizes of segments and sub-segments.

Secondary Research

In the secondary research process, various secondary sources such as D&B Hoovers, Bloomberg Business, and Factiva have been referred to identify and collect information for this study. These secondary sources include annual reports, press releases and investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard and silver-standard websites, regulatory bodies, and databases.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies operating in the patient registry software market. Primary sources from the demand side include experts from hospitals and government organizations and third party associates (tpa) and research centers. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on the key industry trends and key market dynamics, such as market drivers, restraints, challenges, and opportunities.

Patient Registry Software Market   Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the patient registry software market was arrived at after data triangulation from two different approaches, as mentioned below.

Approach to calculate the revenue of different players in the patient registry software market

The size of the patient registry software market was obtained from annual reports, SEC filings, online publications, and extensive primary interviews. A percentage split was applied to arrive at the size of market segments. Further splits were applied to arrive at the size for each sub-segment. These percentage splits were validated by primary participants. The country-level market sizes obtained from the annual reports, SEC filings, online publications, and extensive primary interviews were added up to reach the total market size for regions. By adding up the market sizes for all the regions, the global patient registry software market was derived.

Approach to derive the market size and estimate market growth

The market size and market growth were estimated through primary interviews on a regional and global level. All responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Objectives of the Study

  • To define, describe, and forecast the patient registry software market based on the type of registry, pricing model, deployment model, type of database, functionality, end user, type of software, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, along with major countries in these regions
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies2 in the patient registry software market
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, acquisitions, product developments, geographic expansions, and R&D activities in the patient registry software market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of top companies

Geographic Analysis

  • Further breakdown of the Latin America market into Brazil, Mexico and other countries

Company Information

  • Detailed analysis and profiling of additional market players, up to five
COVID-19

Get in-depth analysis of the COVID-19 impact on the Patient Registry Software Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Patient Registry Software Market

Request For Special Pricing
Report Code
HIT 3094
Published ON
Aug, 2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Patient Registry Software Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2020 MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home